Investigation on the Rehabilitation Efficacy of EMG-Driven Exoneuromusculoskeleton (ENMS) on Upper Limb Motor Function and Its Impact on Gait in Patients with Subacute Stroke

INTERVENTION: Experimental group (neuromusculoskeletal group):Training with external neuromusculoskeletal assistance;Control group (conventional training group):Conventional training; CONDITION: Stroke (including ischemic and hemorrhagic stroke); the study population is limited to patients in the subacute phase. PRIMARY OUTCOME: Upper limb Fugl‐Meyer motor function score; SECONDARY OUTCOME: MyotonPRO Muscle Hardness;Improved Tardieu Scale;Fugl‐Meyer Lower Limb Motor Function Score;Gait assessment and intervention tools;Simple Upper Limb Function Examination;Stroke patient performance assessment scale; INCLUSION CRITERIA: 1. The first occurrence of a stroke (ischemic or hemorrhagic), with a single unilateral brain injury; 2. The onset time is within 1‐6 months; 3. The age is over 18 years old; 4. The degree of motor dysfunction in the upper limb on the hemiplegic side is moderate to severe (15 < FMA‐UE score < 45); 5. The score on the Mini‐Mental State Examination is 21 or above; 6. Autonomous muscle electrical signals can be detected in the driving muscles on the hemiplegic side (i.e., more than three times the standard deviation above the electromyographic baseline); 7. The muscle response quality of the upper and lower limbs on the hemiplegic side on the Modified Tardieu Scale is less than 3 points; 8. BMI <= 30 kg/m^2; 9. The ability to walk independently for a distance of 10 meters.